---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-013823"
form_type: "8-K"
ticker: "PROK"
cik: "0001850270"
company_name: "PROKIDNEY CORP."
filed_at: "2024-02-12T23:59:59+00:00"
generated_at: "2026-06-06T04:28:07.391849+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# ProKidney grants supplemental stock option to Chief Legal Officer Todd Girolamo

## Summary
- Option for 234,742 Class A ordinary shares at FMV on March 1, 2024 grant date.
- Vesting: 50% on March 1, 2025; remainder in equal monthly installments over 12 months.
- Award approved Feb 6, 2024 under 2022 Incentive Equity Plan for retention purposes.

## SEC filing metadata
- accession: 0000950170-24-013823
- form_type: 8-K
- ticker: PROK
- cik: 0001850270
- company_name: PROKIDNEY CORP.
- filed_at: 2024-02-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850270/000095017024013823/0000950170-24-013823-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850270/000095017024013823/prok-20240206.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-013823
- JSON: https://secwatch.observer/filing/0000950170-24-013823.json
- Plain text: https://secwatch.observer/filing/0000950170-24-013823.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.